ACON · Aclarion, Inc. · Metrics
Market Cap
$7.62M
Shares
2.88M
Volume · Oct 2
15.67K
Avg daily vol (3M)
53.38K
ACON metrics
61 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$2.44
Market cap
$7.62M
Price action
20 metricsPrice change (1W)
-7.2%
Price change (30D)
+5.6%
Price change (3M)
-21.0%
Price change (6M)
-31.7%
Price change (YTD)
-47.0%
Price change (1Y)
-67.8%
Trailing year
Price change (5Y)
—
52-week high
$9.69
52-week low
$2.02
Change from 52-week high
-74.8%
Change from 52-week low
+21.1%
Annualized volatility
95.1%
Annualized volatility (3M)
69.7%
Beta
1.1
RSI (14D)
46.9
Price vs SMA 50
-0.4%
Price vs SMA 200
-24.0%
Avg volume (3M)
53,375
Relative volume
0.1
Average dollar volume
$135,425
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
2.88M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
90.9×
reciprocal yield 1.1%
P / book
0.4
reciprocal yield 223.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-120.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
21.8%
Operating margin
-11,592.3%
Trailing 12 months
Net margin
-10,978.6%
Gross profit (TTM)
$18,223
Operating profit (TTM)
−$9.71M
Net income (TTM)
−$9.20M
Trailing 12 months
Diluted EPS (TTM)
$-4.00
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+30.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$83,768
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+322.8%
Year over year · more shares
Revenue CAGR (3Y)
+7.8%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-54.1%
Return on assets
-51.0%
Debt / equity
—
Current ratio
16.2
EBITDA (TTM)
−$9.47M
Free cash flow (TTM)
—
Quick ratio
16.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$16.29M
Latest balance sheet
Cash & equivalents
$16.29M
Total assets
$18.04M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$8.09M
Capital expenditures (TTM)
$22,856
R&D (TTM)
$1.18M
SG&A (TTM)
—
Stock compensation (TTM)
$127,922
R&D / revenue
1,405.8%
Stock compensation / revenue
152.7%
Ownership (13F)
3 metrics13F filers
16
13F filer change QoQ
+5
Institutional ownership
9.0%
Short interest
3 metricsShort interest
2.6%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
64 / 100
Insider activity
2 metricsNet insider buying (90D)
$125,670
Insider-sentiment score
92 / 100
Risk flags
1 metricsGoing concern
—